End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
116.6 BDT | -2.02% | -2.26% | -20.25% |
Mar. 04 | Beximco names Iqbal Ahmed as managing director | AN |
Jan. 30 | Beximco Pharmaceuticals to strengthen portfolio as interim profit up | AN |
Sales 2024 * | 44.55B 408M | Sales 2025 * | 50.49B 463M | Capitalization | 53.09B 487M |
---|---|---|---|---|---|
Net income 2024 * | 5.13B 47.05M | Net income 2025 * | 6B 55M | EV / Sales 2024 * | 1.33 x |
Net Debt 2024 * | 5.99B 54.94M | Net Debt 2025 * | 884M 8.1M | EV / Sales 2025 * | 1.07 x |
P/E ratio 2024 * |
9.67
x | P/E ratio 2025 * |
7.88
x | Employees | 5,700 |
Yield 2024 * |
3.36% | Yield 2025 * |
4.2% | Free-Float | 76.68% |
1 day | -0.17% | ||
1 week | -0.25% | ||
Current month | +2.23% | ||
1 month | +1.54% | ||
3 months | -11.19% | ||
6 months | -18.60% | ||
Current year | -18.60% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 61 | 89-12-31 | |
Chief Tech/Sci/R&D Officer | - | - | |
Selina Akter
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 75-12-31 | |
Founder | - | 75-12-31 | |
Iqbal Ahmed
CEO | Chief Executive Officer | - | 84-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 116.6 | -2.02% | 91 895 |
24-04-23 | 119 | -0.17% | 124,390 |
24-04-22 | 119.2 | +0.25% | 190,856 |
24-04-21 | 118.9 | +1.02% | 150,959 |
24-04-18 | 117.7 | -1.51% | 124,368 |
End-of-day quote Dhaka S.E., April 22, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.60% | 482M | |
+27.92% | 672B | |
+27.20% | 570B | |
-4.59% | 360B | |
+16.38% | 321B | |
+9.39% | 300B | |
+7.43% | 217B | |
+5.46% | 199B | |
-8.47% | 204B | |
-8.58% | 149B |
- Stock Market
- Equities
- BXPHARMA Stock